image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

Craneware - New contract wins

September 2011

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CRW
  • Price:
  • 510p
In its year-end update Craneware, which supplies billing and auditing software to US hospitals, has announced trading in line with expectations with this year’s revenues expected to rise 34% from US$28.4m in 2010 and profit to rise 30% from US$7.6m. Encouragingly, the company's visibility of revenues for the next three years (from its Software as a Service model) has also improved from US$83m as at 30 June 2010 to US$105m as at 30 June 2011. Separately, Craneware has also announced two new contract wins, both from multi-hospital groups. These comprise Shriners Hospitals, a 20-hospital group in Florida and an un-named 10-hospital group also in Florida. No contract values were given but Numis expects US$5-US$8m over their lifespan ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe